OncoMed Chooses SynCo Bio Partners to Fill and Finish its Lea... ( AMSTERDAM April 15 /- SynCo Bio P...)

OncoMed Chooses SynCo Bio Partners to Fill and Finish its Lead Antibody

Date:4/15/2008

AMSTERDAM, April 15 /PRNewswire/ -- SynCo Bio Partners B.V., a leading GMP biopharmaceutical manufacturer, has signed a Master Services Agreement with OncoMed Pharmaceuticals, a company developing novel therapeutics that target cancer stem cells. Under the agreement, SynCo will fill and finish batches of OncoMed's lead product, antibody OMP-21M18, for use in Phase I clinical trials.

Announcing the agreement, Pierre Warffemius, CEO, said, "We are delighted that a company at the forefront of cancer therapies has recognised our expertise in biopharmaceutical processing by choosing us to fill their lead antibody for early clinical trails."

Paul J. Hastings, President and CEO of OncoMed, "We selected SynCo Bio Partners because we needed a GMP-accredited contract manufacturing organisation that had a proven track record in filling biologics. With SynCo's expertise in all aspects of biopharmaceutical manufacture, they were an ideal partner for us at this crucial stage in our development."

OncoMed recently announced that it had signed a worldwide strategic alliance with GSK to develop cancer stem cell antibody therapeutics. One of the key projects in this alliance will be the development of OncoMed's lead antibody product candidate, OMP-21M18, a monoclonal antibody, which is scheduled to enter the clinic in 2008.

SynCo will fill and finish antibody OMP-21M18 at its Amsterdam-based facility. This facility is able to fill a wide range of biopharmaceuticals into vials, including protein, polysaccharide, and live-microbial-based products using the latest filling and finishing equipment.

Issued on behalf of SynCo Bio Partners by De Facto Communications

About SynCo Bio Partners B.V.

SynCo Bio Partners is a GMP-licensed bulk drug substance and final product CMO with in-depth clinical and commercial production experience with mammalian and microbial systems. This experience has been acquired by developing new production proces
'/>"/>

SOURCE SynCo Bio Partners B.V.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2
Related medicine technology :

1. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
2. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
3. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
4. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
5. The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals
6. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
7. UNICEF Partners With Causes on Facebook to Launch Charity Gift Feature
8. HealthMedias Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships
9. iCAD Announces Partnership for Initiating Clinical Testing of Its Virtual Colonoscopy CAD Product
10. Catalyst Pharmaceutical Partners Begins Enrollment for Its U.S. Phase II Clinical Trial of CPP-109 in Patients with Cocaine Addiction
11. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies

Post Your Comments:

(Date:6/18/2013)... N.J. and NEW YORK , ... and Company) (NYSE: BDX ) are accelerating the ... and glucose sensing technologies through a new collaboration announced today. ... collaborations focused on type 1 diabetes (T1D). Many ... insulin pump – requiring a catheter to be placed in ...

(Date:6/18/2013)... Today, Wall Street Reports announced new research reports ... Management Associates Inc. (NYSE: HMA ), IDEXX Laboratories, ... ISIS ), and Trius Therapeutics Inc. (NASDAQ: TSRX). ... including full price targets, industry analysis and analyst ratings - ... Report On June 7, 2013, Gilead Sciences Inc. ...

(Date:6/18/2013)... June 18, 2013 Remedy Informatics, a ... and life sciences research, today announced it has ... IT Schedule 70 supply contract (GS-35F-367AA, effective May ... innovative IT solutions to government agencies at federal, ... contract, Remedy has placed its products and services ...

Breaking Medicine Technology:JDRF Extends Collaboration with BD to Develop Combined Infusion and Monitoring Products for People with Type 1 Diabetes 2 JDRF Extends Collaboration with BD to Develop Combined Infusion and Monitoring Products for People with Type 1 Diabetes 3 Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 2 Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 3 Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 4 Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 5 Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics 6 Remedy Informatics Awarded GSA Contract to Provide Innovative IT Solutions to Federal, State and Local Agencies 2 Remedy Informatics Awarded GSA Contract to Provide Innovative IT Solutions to Federal, State and Local Agencies 3 Remedy Informatics Awarded GSA Contract to Provide Innovative IT Solutions to Federal, State and Local Agencies 4

[0] JDRF Extends Collaboration with BD to Develop Combined Infusion and Monitoring Products for People with Type 1 Diabetes [0] Industry Shows a Healthy Pulse with Priority Reviews, Positive Results, New Testing Procedures, and Partnerships - Research Report on Gilead, Health Management, IDEXX, ISIS, and Trius Therapeutics [0] Remedy Informatics Awarded GSA Contract to Provide Innovative IT Solutions to Federal, State and Local Agencies

... Lexicon Pharmaceuticals, Inc. (Nasdaq: ... treatments for human disease, announced today that Arthur ... executive officer, will present at the Morgan Stanley Global ... 14, 2011 at 9:10 a.m. Eastern Time. Dr. Sands ...

... Sept. 5, 2011 Reportlinker.com ... research report is available in ... Facial Aesthetics (Botox, Dermal Fillers, ... Competitive Landscape and Market Forecasts ...

Lexicon Pharmaceuticals to Present at Morgan Stanley Global Healthcare Conference Facial Aesthetics (Botox, Dermal Fillers, Collagen) - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017

(Date:6/18/2013)... (PRWEB) June 18, 2013 Biomet ... continue to move forward in a multidistrict litigation in ... LLP reports. According to court records, the litigation’s ... at which time the Court also convened a motions ... issues pertinent to the Biomet hip replacement litigation. ...

(Date:6/18/2013)... Seven-year-old Riley Salz of Encino, California, is ... 40 hours a week of applied behavior analysis (ABA) ... for Autism and Related Disorders (CARD). Riley has been ... experienced remarkable progress, including learning to speak, starting conversations, ... journey through autism is now featured in CARD’s “Mission ...

(Date:6/18/2013)... Recent research has shown that cancer cells have a ... normal cells. Now, scientists at The University of Texas ... provide a new strategy to combat lung cancer. , ... journal PLOS ONE , UT Dallas researchers compared ... normal lung cells taken from the same patient. ...

(Date:6/18/2013)... at Case Western Reserve University,s College of Arts ... made available avatarsvirtual patientsto train speech-language pathologists. ... to evaluate speech-language disorders to practice using an ... because a diagnosis doesn,t have to be made ... studying to become speech-language pathologists have previously relied ...

(Date:6/18/2013)... Belleville, Ill. (PRWEB) June 18, 2013 More ... older are living with HIV/AIDS, according to the Centers for ... don’t know they are infected. In support of National HIV ... Social Security Disability Insurance (SSDI) representation, the CDC ... HIV testing. , The CDC reports about 50,000 new ...

Breaking Medicine News(10 mins):Health News:Biomet Hip Lawsuit News: Bernstein Liebhard LLP Reports on Latest Status Conference in Federal Biomet Hip Replacement Litigation 2 Health News:Biomet Hip Lawsuit News: Bernstein Liebhard LLP Reports on Latest Status Conference in Federal Biomet Hip Replacement Litigation 3 Health News:June's Release of CARD's "Mission Possible: Portraits of Hope" Features Southern California Child and His Remarkable Progress with Intensive Autism Therapy 2 Health News:June's Release of CARD's "Mission Possible: Portraits of Hope" Features Southern California Child and His Remarkable Progress with Intensive Autism Therapy 3 Health News:UT Dallas study suggests new approach to fight lung cancer 2 Health News:UT Dallas study suggests new approach to fight lung cancer 3 Health News:SimuCase avatars advance speech-language pathology training 2 Health News:Allsup Observes National HIV Testing Day June 27 2 Health News:Allsup Observes National HIV Testing Day June 27 3

[0] Biomet Hip Lawsuit News: Bernstein Liebhard LLP Reports on Latest Status Conference in Federal Biomet Hip Replacement Litigation [0] June's Release of CARD's "Mission Possible: Portraits of Hope" Features Southern California Child and His Remarkable Progress with Intensive Autism Therapy [0] UT Dallas study suggests new approach to fight lung cancer [0] SimuCase avatars advance speech-language pathology training [0] Allsup Observes National HIV Testing Day June 27

... boosted hearing in such children , THURSDAY, Feb. ... hearing improvement for children and teens with single-sided deafness, ... 3 percent of children have deafness on one side, ... difficulties and behavioral problems. Traditional external hearing aids are ...

... ... NFL Draft pick would have to find a personal trainer, physical therapist, ... them compete with the best athletes in the world. But Athletes, ... offered an NFL Combine preparation program, and this year Trigger Point Performance ...

... , Scientists at the Johns Hopkins Kimmel Cancer Center ... cancer patients to develop individualized blood tests they believe ... blood tests, believed to be the first of their ... therapy and determine cancer recurrence., "We believe this ...

... It is not unusual to hear people blame their metabolism ... process that shapes how our bodies turn food into energy -- ... fit into your favorite jeans. In fact, differences in ... cells, though the mechanism behind it is unclear. Now new research ...

... patients perform significantly better on tests of cognitive function than ... MRI scans of the patients showed that the fitter MS ... show deterioration as a result of MS, as well as ... that aerobic fitness has a protective effect on parts of ...

... ... Opinion Survey and Special Supplement on Health Care Reform , ... Indianapolis, IN (Vocus) February 18, 2010 -- ... benefits advisory organizations, today announced the opening of the 2010 UBA Employer Opinion ...

Cached Medicine News:Health News:Small Time Company Rolls into the Big League: Trigger Point Performance Therapy Selected to Attend Athletes' Performance NFL Combine Preparation Program 2 Health News:Small Time Company Rolls into the Big League: Trigger Point Performance Therapy Selected to Attend Athletes' Performance NFL Combine Preparation Program 3 Health News:Johns Hopkins scientists develop personalized blood tests for cancer using whole genome sequencing 2 Health News:Johns Hopkins scientists develop personalized blood tests for cancer using whole genome sequencing 3 Health News:Chemical tags likely to affect metabolism, cancer development 2 Health News:Exercise helps protect brain of multiple sclerosis patients 2 Health News:Exercise helps protect brain of multiple sclerosis patients 3 Health News:Employers Voice Opinions on Health Care Plans, Gain Insights on Health Care Reform 2 Health News:Employers Voice Opinions on Health Care Plans, Gain Insights on Health Care Reform 3

Device Helps Kids With Single-Sided Deafness Small Time Company Rolls into the Big League: Trigger Point Performance Therapy Selected to Attend Athletes' Performance NFL Combine Preparation Program Johns Hopkins scientists develop personalized blood tests for cancer using whole genome sequencing Chemical tags likely to affect metabolism, cancer development Exercise helps protect brain of multiple sclerosis patients Employers Voice Opinions on Health Care Plans, Gain Insights on Health Care Reform

Iron / TIBC (Ferrozine). Storage temp: 2 - 8 C. Linearity: 0 - 500 ug/dl. Expected values: from TIBC 250 - 400 ug/dl, from Iron 40 - 160 ug/dl. Available with Calibrator and Number of test are 100....

For the quantitative determination of iron, total iron-binding capacity in human serum....

HDL Cholesterol, liquid....

Intended for the quantitative in vitro enzymatic determination of JDL-Cholesterol in human serum or plasma. Two point reaction. Wavelength: 600 nm. Linearity: 1 to 150 mg/dL (0.03 mmol/L to 3.89 mmol...

Medicine Products:

Iron / TIBC (Ferrozine)Iron/TIBC Reagent Set HDL Cholesterol (Precipitation)HDL-Cholesterol Direct Reagent